Mouse papillomavirus infection persists in mucosal tissues of an immunocompetent mouse strain and progresses to cancer

[1]  D. Gotte,et al.  Mouse papillomavirus infections spread to cutaneous sites with progression to malignancy. , 2017, The Journal of general virology.

[2]  N. Christensen,et al.  The Mouse Papillomavirus Infection Model , 2017, Viruses.

[3]  A. Saah,et al.  Immunogenicity of the 9-Valent HPV Vaccine Using 2-Dose Regimens in Girls and Boys vs a 3-Dose Regimen in Women. , 2016, JAMA.

[4]  R. Roden,et al.  Spontaneous and Vaccine-Induced Clearance of Mus Musculus Papillomavirus 1 Infection , 2017, Journal of Virology.

[5]  N. Christensen,et al.  Recent advances in preclinical model systems for papillomaviruses. , 2017, Virus research.

[6]  M. Grace,et al.  Cutaneous HPV8 and MmuPV1 E6 Proteins Target the NOTCH and TGF-β Tumor Suppressors to Inhibit Differentiation and Sustain Keratinocyte Proliferation , 2017, PLoS pathogens.

[7]  Ronald W. Jones,et al.  The Natural History of Vulvar Intraepithelial Neoplasia, Differentiated Type: Evidence for Progression and Diagnostic Challenges , 2016, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[8]  M. Sugiyama,et al.  Risk Factors for Oral Human Papillomavirus Infection in Healthy Individuals: A Systematic Review and Meta-Analysis , 2016, Journal of clinical medicine research.

[9]  I. Frazer,et al.  Role of Ultraviolet Radiation in Papillomavirus-Induced Disease , 2016, PLoS pathogens.

[10]  P. Ravenda,et al.  Anal human papillomavirus infection: prevalence, diagnosis and treatment of related lesions , 2016, Expert review of anti-infective therapy.

[11]  A. Forastiere,et al.  Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment. , 2016, Mayo Clinic proceedings.

[12]  J. Sundberg,et al.  MmuPV1 infection and tumor development of T cell-deficient mice is prevented by passively transferred hyperimmune sera from normal congenic mice immunized with MmuPV1 virus-like particles (VLPs). , 2016, Experimental and molecular pathology.

[13]  S. H. van der Burg,et al.  Vaccination against Oncoproteins of HPV16 for Noninvasive Vulvar/Vaginal Lesions: Lesion Clearance Is Related to the Strength of the T-Cell Response , 2016, Clinical Cancer Research.

[14]  N. Christensen,et al.  Mouse papillomavirus MmuPV1 infects oral mucosa and preferentially targets the base of the tongue. , 2016, Virology.

[15]  N. Christensen,et al.  Tracking vaginal, anal and oral infection in a mouse papillomavirus infection model. , 2015, The Journal of general virology.

[16]  R. Roden,et al.  Immunologic Control of Mus musculus Papillomavirus Type 1 , 2015, PLoS pathogens.

[17]  M. Nakagawa,et al.  Early Defensive Mechanisms against Human Papillomavirus Infection , 2015, Clinical and Vaccine Immunology.

[18]  N. Christensen,et al.  A Novel Pre-Clinical Murine Model to Study the Life Cycle and Progression of Cervical and Anal Papillomavirus Infections , 2015, PloS one.

[19]  J. Sundberg,et al.  Immune Status, Strain Background, and Anatomic Site of Inoculation Affect Mouse Papillomavirus (MmuPV1) Induction of Exophytic Papillomas or Endophytic Trichoblastomas , 2014, PloS one.

[20]  B. Monk,et al.  New Strategies in Advanced Cervical Cancer: From Angiogenesis Blockade to Immunotherapy , 2014, Clinical Cancer Research.

[21]  D. Lowy,et al.  Strain-Specific Properties and T Cells Regulate the Susceptibility to Papilloma Induction by Mus musculus Papillomavirus 1 , 2014, PLoS pathogens.

[22]  H. Rees,et al.  HPV vaccines to prevent cervical cancer and genital warts: an update. , 2014, Vaccine.

[23]  A. Contreras-Paredes,et al.  Role of Innate Immunity against Human Papillomavirus (HPV) Infections and Effect of Adjuvants in Promoting Specific Immune Response , 2013, Viruses.

[24]  D. Lowy,et al.  Characterization of Mus musculus Papillomavirus 1 Infection In Situ Reveals an Unusual Pattern of Late Gene Expression and Capsid Protein Localization , 2013, Journal of Virology.

[25]  N. Christensen,et al.  Secondary Infections, Expanded Tissue Tropism, and Evidence for Malignant Potential in Immunocompromised Mice Infected with Mus musculus Papillomavirus 1 DNA and Virus , 2013, Journal of Virology.

[26]  M. Krzyżowska,et al.  [Innate immunity to infection in the lower female genital tract]. , 2013, Postepy higieny i medycyny doswiadczalnej.

[27]  D. Kremsdorf,et al.  Detection and genotyping of human papillomavirus by real-time PCR assay. , 2013, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[28]  M. Gottschling,et al.  Isolation of Three Novel Rat and Mouse Papillomaviruses and Their Genomic Characterization , 2012, PloS one.

[29]  J. Sundberg,et al.  Novel Laboratory Mouse Papillomavirus (MusPV) Infection , 2011, Veterinary pathology.

[30]  N. Christensen,et al.  Detection of L1, infectious virions and anti-L1 antibody in domestic rabbits infected with cottontail rabbit papillomavirus. , 2007, The Journal of general virology.

[31]  M. Van Ranst,et al.  Complete genomic characterization of a murine papillomavirus isolated from papillomatous lesions of a European harvest mouse (Micromys minutus). , 2007, The Journal of general virology.

[32]  N. Christensen,et al.  An HLA-A2.1-Transgenic Rabbit Model to Study Immunity to Papillomavirus Infection1 , 2006, The Journal of Immunology.

[33]  N. Christensen.  Cottontail Rabbit Papillomavirus (CRPV) Model System to Test Antiviral and Immunotherapeutic Strategies , 2005, Antiviral chemistry & chemotherapy.

[34]  T. Iftner,et al.  Gene Profiling of Cottontail Rabbit Papillomavirus-Induced Carcinomas Identifies Upregulated Genes Directly Involved in Stroma Invasion as Shown by Small Interfering RNA-Mediated Gene Silencing , 2004, Journal of Virology.

[35]  J. Palefsky,et al.  The Impact of HIV Antiviral Therapy on Human Papillomavirus (Hpv) Infections and Hpv-Related Diseases , 2004, Antiviral therapy.

[36]  M. Campo,et al.  Animal models of papillomavirus pathogenesis. , 2002, Virus research.

[37]  K. Sotlar,et al.  Life Cycle Heterogeneity in Animal Models of Human Papillomavirus-Associated Disease , 2002, Journal of Virology.

[38]  J. Salmon,et al.  The rabbit viral skin papillomas and carcinomas: a model for the immunogenetics of HPV-associated carcinogenesis. , 1997, Clinics in dermatology.

[39]  L. Gissmann,et al.  Mastomys natalensis papilloma virus (MnPV), the causative agent of epithelial proliferations: characterization of the virus particle. , 1978, The Journal of general virology.

[40]  N. Christensen,et al.  Long-peptide therapeutic vaccination against CRPV-induced papillomas in HLA-A2.1 transgenic rabbits. , 2014, Trials in vaccinology.

[41]  J. Reichelt,et al.  Establishment of spontaneously immortalized keratinocyte lines from wild-type and mutant mice. , 2010, Methods in molecular biology.

[42]  J. Brandsma.  The cottontail rabbit papillomavirus model of high-risk HPV-induced disease. , 2005, Methods in molecular medicine.